APA (7th ed.) Citation

K, N., A, Y., M, M., K, O., M, W., K, I., . . . M, A. (2024). Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: A systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology. International journal of clinical oncology, 29(12), 1785. https://doi.org/10.1007/s10147-024-02643-8

Chicago Style (17th ed.) Citation

K, Nakashima, et al. "Efficacy and Safety of Dexamethasone Sparing for the Prevention of Nausea and Vomiting Associated with Moderately Emetogenic Chemotherapy: A Systematic Review and Meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology." International Journal of Clinical Oncology 29, no. 12 (2024): 1785. https://doi.org/10.1007/s10147-024-02643-8.

MLA (9th ed.) Citation

K, Nakashima, et al. "Efficacy and Safety of Dexamethasone Sparing for the Prevention of Nausea and Vomiting Associated with Moderately Emetogenic Chemotherapy: A Systematic Review and Meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology." International Journal of Clinical Oncology, vol. 29, no. 12, 2024, p. 1785, https://doi.org/10.1007/s10147-024-02643-8.